Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac

Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac

<p dir="ltr">Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac. A, B) The top significantly down (A) and up (B) regulated GO pathways in AD-MSC in comparison with PSCs treated with Muc5ac-proficient (KCT3266) or deficient (KCT3266 Muc5ac KO) CM. C, D) T...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Sushil Kumar (20371917) (author)
Vydáno: 2025
Témata:
Cancer cell biology
pancreatic cancer
CAF heterogeneity
epigenetics
Muc5ac
stroma
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:<p dir="ltr">Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac. A, B) The top significantly down (A) and up (B) regulated GO pathways in AD-MSC in comparison with PSCs treated with Muc5ac-proficient (KCT3266) or deficient (KCT3266 Muc5ac KO) CM. C, D) The top significantly upregulated KEGG and Reactome in the AD-MSCs (C) and PSCs (D) treated with Muc5ac-proficient (KCT3266) or deficient (KCT3266 Muc5ac KO) CM.</p>

Podobné jednotky